Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 637-642

  Li, Hewei ^a   Alonso Vanegas, Mario ^a   Colicos, Michael A ^a   Jung, Sonia S ^a   Lochmuller, Hanns ^a,d   Sadikot, Abbas F ^a   Snipes, G Jackson ^b   Seth, Prem ^c   Karpati, George ^a   Nalbantoglu, Josephine ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53;

ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN TUMOR; CELL DEATH; CONTROLLED STUDY; DNA TRANSFECTION; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE MUTATION; GENE THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; DISEASE PROGRESSION; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032999533     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kleihues, P., Soylemezoglu, F., Schauble, B., Scheithauer, B. W., and Burger, P. C. Histopathology, classification and grading of gliomas. Glia, 15: 211-221, 1995.
2. Fults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A., and Cawthon. R. M. p53 mutations and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
3. von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., and Wiestler, O. D. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
4. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavenee, W. K., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature (Lond.), 355: 846-847, 1992.
5. Wieczorek, A. M., Waterman, J. L. F., Waterman, M. J. F., and Halazonetis, T. D. Structure-based rescue of common tumor-derived p53 mutants. Nat. Med., 2: 1143-1146, 1996.
6. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C. Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., and McCormick, F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science (Washington DC), 274: 373-376, 1996.
7. Louis, D. N. The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol., 53: 11-21, 1993.
8. van Meir, E. G., Roemer, K., Diserens, A-C., Kikuchi, T., Rempel, S. A., Haas, M., Huang, H. J., Friedmann, T. L., de Tribolet, N., and Cavenee, W. K. Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. Proc. Natl. Acad. Sci. USA, 92: 1008-1012, 1995.
9. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., Steck, P. A., Roth, J. A., McDonnell, T. J., Steck, K. D., Levin, V. A., and Yung, W. K. A. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res., 56: 694-699, 1996.
10. Li, H. W., Lochmuller, H., Yong, V. W., Karpati, G., and Nalbantoglu, J. Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J. Neuropathol. Exp. Neurol., 56: 872-878, 1997.
11. Elledge, R. M., and Lee, W. H. Life and death by p53. Bioessays, 17: 923-930, 1995.
12. Chen, X., Ko, L. J., Jayaraman, L., and Prives, C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev., 10: 2438-2451, 1996.
13. Asai, A., Miyagi, Y., Sugiyama, A., Gamanuma, M., Hong, S. H., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., and Kuchino, Y. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. J. Neuro-Oncol., 19: 259-268, 1994.
14. Kayatose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
15. Acsadi, G., Jani, A., Massie, B., Simoneau, M., Holland, P., Blaschuk, K., and Karpati, G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet., 3: 579-584, 1994.
16. Lochmuller, H., Jani, A., Huard, J., Prescott, S., Simoneau, M., Massie, B., Karpati, G., and Acsadi, G. Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔEl + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther., 5: 1485-1491, 1994.
17. Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., and Coen, D. M. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science (Washington DC), 252: 854-856, 1991.
18. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
19. Byrnes, A. P., Rusby, J. E., Wood, M. J. A., and Charlton, H. M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience, 66: 1015-1024, 1995.
20. Durham, H. D., Alonso-Vanegas, M., Sadikot, A. F., Zhu, L. X., Lochmuller, H., Massie, B., Nalbantoglu, J., and Karpati, G. The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer. Neuroreport, 8: 2111-2115, 1997.